Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
† Study has passed its completion date and status has not been verified in more than two years.